Viramed Biotech AG


    • Company type:
      • Manufacturer
    • Year founded:
    • 1983
    • Employees (at the site):
    • 35
    • Turnover range:
    • 10m - <50m EUR
    • Products/services:
    • Diagnostics for Human Infectious Diseases and Autoimmune Disorders
      Clinical Diagnostics, ELISA / EIA, Infectious Diseases

    • Core competencies:
    • Based on 20 successful years on the German IVD-Market, Viramed Biotech AG produces and markets IVD-Products, based on its proprietary research and development. The company focuses on Westernblot-, Stripe- and Elisa-test kits for serological screening and confirmation of infectious and autoimmune diseases. The major products are Westernblot tests for Borrelia sp., Yersinia, Heliocbacter p., Epstein-Barr-Virus, Bordetella pertussis, ENA and autoimmune liver diseases. New analytics based on purified and recombinant antigens are under development. The development of antigens and test kits for specific analytics are offered as service. The company aims to intensify export of existing products worldwide and appreciates further distribution contacts.

    • Language skills:
    • English
    • Key Tech / section:
      • Biotechnology: Biotechnological devices
      • Biotechnology: Molecular diagnostics for humans
    • Industries NACE:
      • 26.6: Manufacture of irradiation, electromedical and electrotherapeutic equipment
    • Certification:
    • not available

    • Sales markets - target industries:
    • not available
    • Sales markets - target countries:
    • not available
    • Cooperation offers:
    • not available
    • Contact person:
    • Dr. Martin Kintrup (Mr.)
      - Management